G. Surgiwear IPO: GMP, Pricing Details, Allotment Insights, and 2026 Profit Estimates Revealed!

G. Surgiwear is set to launch its IPO, focusing on surgical consumables and implantable medical devices. Established in 1990, it has a strong presence in the medical devices industry with an extensive product range, including disposable surgical drapes and dressings. The IPO will comprise a fresh issue of INR 370 crore and an offer for sale of INR 370 crore, totaling INR 740 crore. Listing is anticipated on both the NSE and BSE, with more specific dates and pricing details still to be announced. The minimum bid and lot size will also be revealed closer to the opening of the subscription period.

Currently, in the grey market, the sentiment around G. Surgiwear’s IPO appears to be cautiously optimistic among investors, contributing to speculation about potential listing gains. The company’s robust financial performance, highlighted by increasing revenues and profits over the past few years, further enhances the appeal of the stock. Investors are particularly optimistic about the strong demand for surgical products in both domestic and international markets, which could provide a solid foundation for G. Surgiwear’s growth trajectory post-IPO.

For Indian investors, the G. Surgiwear IPO presents a compelling opportunity to participate in a growing sector with significant demand for medical devices. Given the company’s established history and expanding product portfolio, the IPO could attract considerable attention from retail and institutional investors alike. As the subscription details are finalized, investors would do well to monitor the grey market sentiments and overall market conditions to make informed decisions regarding their participation in this offering.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)